Clinical trial
Validation of Prognostic Markers for Very Low Risk Wilms Tumors
NCT01004783 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Validation of Prognostic Markers for Very Low Risk Wilms Tumors
- Lead sponsor
- Children's Oncology Group
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 31, 2009
- Completion date
- November 30, 2010
- Enrollment
- 165 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
kidney cancer